Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107417615A enables visible light promoted synthesis of chiral quinolinone derivatives. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN110041361B reveals a visible-light driven tandem reaction for high-purity cyclopropane intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN114345370A details a Cu-doped CdS quantum dot photocatalyst for C-C bond formation. Offers green synthesis for pharmaceutical intermediates with reduced costs.
Patent CN114685298A reveals a green photocatalytic route for baclofen. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN108484500B reveals a mild iridium-catalyzed route for 1-trifluoroethyl isoquinoline intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN117603023A reveals metal-free deuteration. Enhances purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN115232164B reveals a visible-light catalyzed method for sulfonyl thiophosphates. This process offers mild conditions and high atom economy for reliable agrochemical intermediate supplier.
Patent CN115232164B enables efficient sulfonyl thiophosphate production via visible light photocatalysis. Offers cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN111848628A reveals a green g-C3N4 catalyzed route for high-purity intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN103467282A details a mild, iridium-catalyzed visible light method for synthesizing polysubstituted naphthols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114890908B reveals a catalytic method for gamma-trifluoromethyl amino acids using Togni reagents, offering cost reduction in API manufacturing and scalable production.
Novel 5-step synthesis route for entecavir intermediate offers high yield and scalable production for pharmaceutical supply chains.
Patent CN112279754B reveals a mild blue-light photocatalytic route for fluorinated sesquiterpenes, offering cost-effective scaling for pharmaceutical intermediates.
Patent CN115043846B details a visible-light catalyzed route for pyrroloindole derivatives, offering scalable manufacturing and cost-effective pharmaceutical intermediate production.
Patent CN113292633B enables catalyst-free visible light hydrazine modification. Offers high purity unnatural amino acids with reduced manufacturing costs and scalable supply chain reliability.
Patent CN116574072A details a green visible-light method for 2,5-diaryl furans. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Ir-catalyzed visible light method for polysubstituted cyclopropanes. Enhances yield, reduces by-products, ensures scalable API intermediate production.
Patent CN114835660A reveals a metal-free, visible-light mediated method for oxime ether synthesis, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114773284B details a visible light-mediated synthesis of dihydroisoxazoles using terminal olefins. Offers mild conditions and cost-effective raw materials for pharmaceutical intermediates.